Prosecution Insights
Last updated: May 04, 2026
Application No. 18/974,861

METHOD OF PREPARING 2-HYDROXYADPIC ACID AND ADIPIC ACID

Final Rejection §112
Filed
Dec 10, 2024
Priority
Jun 14, 2024 — TW 113122130
Examiner
WONG, EDNA
Art Unit
1795
Tech Center
1700 — Chemical & Materials Engineering
Assignee
National Cheng Kung University
OA Round
2 (Final)
58%
Grant Probability
Moderate
3-4
OA Rounds
1y 8m
Est. Remaining
39%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allowance Rate
604 granted / 1038 resolved
-6.8% vs TC avg
Minimal -19% lift
Without
With
+-19.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
40 currently pending
Career history
1078
Total Applications
across all art units

Statute-Specific Performance

§101
0.1%
-39.9% vs TC avg
§103
41.6%
+1.6% vs TC avg
§102
16.4%
-23.6% vs TC avg
§112
36.7%
-3.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1038 resolved cases

Office Action

§112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . This is in response to the Amendment dated March 19, 2026. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office Action. Response to Amendment Election/Restrictions This application contains claims 8-10 (method) drawn to an invention nonelected with traverse in the reply filed on November 27, 2025. A complete reply to the final rejection must include cancellation of nonelected claims or other appropriate action. See MPEP § 821.01. Specification The disclosure has been objected to because of minor informalities. The objection of the disclosure has been withdrawn in view of Applicant’s amendment. Claim Objections Claims 1-7 have been objected to because of minor informalities. The objection of claims 1-7 has been withdrawn in view of Applicant’s amendment. Claim Rejections - 35 USC § 112 Claim 7 has been rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. The rejection of claim 7 under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, has been withdrawn in view of Applicant’s amendment. Continued Response Claim Objections Claims 1-7 are objected to because of the following informalities: Claim 1 line 2, please amend the word “a” to the word -- the --. Appropriate correction is required. Response to Arguments Election/Restrictions Claims 1-7 are allowable. The restriction requirement between inventions, as set forth in the Office action mailed on October 10, 2025, has been reconsidered in view of the allowability of claims to the elected invention pursuant to MPEP § 821.04(a). The restriction requirement is hereby withdrawn as to any claim that requires all the limitations of an allowable claim. Specifically, the restriction requirement of October 10, 2025 is not withdrawn because claims 8- 10, directed to a method of preparing 2-hydroxyadipic acid, remain withdrawn from consideration because they do not require all the limitations of an allowable claim. Allowable Subject Matter The following is a statement of reasons for the indication of allowable subject matter: Claims 1-7 define over the prior art of record because the prior art does not contain any language that teaches or suggests a method of preparing 2-hydroxyadipic acid and adipic acid comprising a step of electrolyzing as presently claimed, esp., wherein the quaternary ammonium salt is represented by formula (I): PNG media_image1.png 194 289 media_image1.png Greyscale wherein R1 to R4 are independently a C2-5 hydrocarbon group, and X- is ClO4-, H2PO4-, or Br-. Therefore, a person skilled in the art would not have been motivated to adopt the above conditions, and a prima facie case of obviousness cannot be established. WO 2018/097725 does not teach a sulfuric acid solution containing a quaternary ammonium salt wherein the quaternary ammonium salt is represented by formula (I). Claims 1-7 would be allowable if rewritten or amended to overcome the claim objection(s) set forth in this Office action. THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to EDNA WONG whose telephone number is (571) 272-1349. The examiner can normally be reached Monday-Friday, 7:00 AM- 3:30 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Luan Van can be reached at (571) 272-8521. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /EDNA WONG/Primary Examiner, Art Unit 1795
Read full office action

Prosecution Timeline

Dec 10, 2024
Application Filed
Jan 13, 2026
Non-Final Rejection — §112
Mar 19, 2026
Response Filed
Apr 19, 2026
Final Rejection — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12612709
METHOD OF INHIBITING TARNISH FORMATION AND CORROSION
3y 3m to grant Granted Apr 28, 2026
Patent 12606926
SURFACE TREATMENT METHOD OF ALUMINUM MATERIAL
2y 6m to grant Granted Apr 21, 2026
Patent 12605488
SURFACE TREATMENT METHODS FOR CEMENTLESS IMPLANTABLE MEDICAL DEVICES
2y 4m to grant Granted Apr 21, 2026
Patent 12606919
Multi-Metal Electrocatalytic System for Methane Oxidation
2y 2m to grant Granted Apr 21, 2026
Patent 12601067
ELECTROCHEMICAL OXIDATION OF CYCLOALKENES AND CYCLOALKANES INTO ALPHA, OMEGA-DICARBOXYLIC ACIDS OR INTO KETOCARBOXYLIC ACIDS AND CYCLOALKANONE COMPOUNDS
1y 6m to grant Granted Apr 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
58%
Grant Probability
39%
With Interview (-19.1%)
3y 1m (~1y 8m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1038 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month